ProCE Banner Activity

Relapsed/Refractory Multiple Myeloma: Subsequent Therapy and Beyond

Slideset Download
Download these expert-selected slides on current best practices for later-stage relapsed/refractory multiple myeloma and investigational agents in this setting.

Released: June 07, 2022

Expiration: June 06, 2023

No longer available for credit.

Share

Faculty

Paul G. Richardson

Paul G. Richardson, MD

Associate Professor of Medicine
Harvard Medical School
Clinical Director
Jerome Lipper Multiple Myeloma Center
Dana-Farber Cancer Institute
Boston, Massachusetts

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by educational grants from

AbbVie Inc.

GlaxoSmithKline

Janssen administered by Scientific Affairs

Karyopharm Therapeutics

Regeneron Pharmaceuticals, Inc.

Program Director Disclosure

Program Director

Paul G. Richardson, MD

Associate Professor of Medicine
Harvard Medical School
Clinical Director
Jerome Lipper Multiple Myeloma Center
Dana-Farber Cancer Institute
Boston, Massachusetts